Scorpion a-toxins are polypeptides that inhibit voltage-gated sodium channel inactivation. They are divided into mammal, insect and a-like toxins based on their relative activity toward different phyla. Several factors are currently known to influence the selectivity, which are not just particular amino acid residues but also general physical, chemical, and topological properties of toxin structural modules. The objective of this study was to change the selectivity profile of a chosen broadly active a-like toxin, BeM9 from Mesobuthus eupeus, toward mammal-selective. Based on the available information on what determines scorpion a-toxin selectivity, we designed and produced msBeM9, a BeM9 derivative, which was verified to be exclusively active toward mammalian sodium channels and, most importantly, toward the Na v 1.2 isoform expressed in the brain.
Animal venoms present a vast potential as a source of isoform-specific ligands of ion channels. In particular, scorpion venoms contain polypeptides affecting voltage-gated sodium channels (Na v s). These polypeptides are 60-70 amino acid residues long and are generally divided into two large groups: a-and b-toxins [1] . Scorpion a-toxins inhibit the fast inactivation of Na v , while b-toxins facilitate Na v activation. a-Toxins have a wide activity profile affecting Na v of lizards, birds, snakes, insects, rodents, etc. [2] . Current classification of a-toxins is based on their taxonomic specificity. They are divided into mammal toxins, insect toxins, and a-like toxins, the latter subgroup affecting both insects and mammals but having a weak effect on channels expressed in the mammalian brain [3, 4] .
Voltage-gated sodium channels are ion channels consisting of a major a-subunit and usually one or two ancillary b-subunits. The pore-forming a-subunit ( Fig. 1) is comprised of four polypeptide repeats numerated from I to IV and contains binding sites for various toxins and other ligands, so-called receptor sites [5] . Each repeat forms six transmembrane a-helical segments named S1-S6. The S5 and S6 helices jointly with the pore helices P1 and P2 connected to the extracellular S5-P1 and P2-S6 loops from each repeat together form the sole pore domain, which allows ion flow upon channel activation. Helical bundles formed by S1-S4 helices of every repeat serve as voltage-sensing domains (VSDs). It is common view that VSDs I-III are responsible for the activation of Na v s, while VSD-IV is responsible for the inactivation [6] , it is this fourth domain where scorpion a-toxins bind as shown by surface plasmon resonance [7] and extensive mutagenesis (see below).
Scorpion a-toxins possess modular structure, mirroring the domain architecture of Na v s, and consist of a rigid core module and a relatively flexible specificity module [8] . The core module is the 'fist' of a-toxins being formed by a babb scaffold stabilized by three conserved disulfide bridges and an aromatic cluster [9] . It is assumed to bind to the extracellular loops of VSD-IV of Na v s. The specificity module is comprised of the so-called 'RC-domain', which includes a five-residue reverse turn (so-called 'RT-loop') and the C-terminus, and the b 2 -b 3 loop. It is responsible for distinguishing between Na v isoforms of different taxons and is proposed to interact with the S5-P1/P2-S6 loops of Na v repeat I [8, 10] . Mammal, insect, and a-like toxins show differences in topology, hydrophobicity, and mobility of the specificity modules [8, 11] . Thorough mutagenesis studies revealed certain amino acid residues being important for scorpion a-toxin selectivity [9, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . A few works also demonstrated that the interchange of the 'RC-domains' and individual residues of the core domain between representative mammal toxins Lqh2 and Aah2 and representative insect toxin LqhaIT was sufficient to change their selectivity [17, 21] .
Rational design attracts scientists for decades. In the scope of the present study, we used a rational approach to change the specificity of a scorpion a-like toxin. We compiled a comprehensive list of all scorpion a-toxins with a defined selectivity profile and conducted a thorough analysis of literature to define factors that influence scorpion a-toxin selectivity. We defined specific residues that provide mammal selectivity in a-toxins. To verify our considerations, we designed a derivative of the a-like scorpion toxin BeM9 from Mesobuthus eupeus [26] , produced this derivative recombinantly and described its activity on Na v channels.
Materials and methods

Production of BeM9 and its derivative
BeM9 was produced recombinantly as described previously [8] , and its derivative msBeM9 was produced following the same procedure. The pET32b-BeM9 vector was produced in the scope of the previous work [8] and pET32b-msBeM9 vector was obtained from Evrogen. Both vectors were used to transform Escherichia coli Origami B cells. Gene expression was induced by 0.2 mM isopropyl-D-1-thiogalactopyranoside and then the cells were incubated at room temperature overnight. Fusion proteins comprising a carrier protein thioredoxin, (His) 6 -tag, and a methionine residue immediately preceding the target polypeptide were purified from cell lysate using metal affinity chromatography on a HisPur Cobalt Resin (Thermo Fisher Scientific, Waltham, MA, USA) following the manufacturer's protocol. Fusion proteins were then cleaved at methionine residues by cyanogen bromide following a published protocol [27] . The target polypeptides were purified using two-step reversephase HPLC: on the first step, the hydrolysate was separated using a Jupiter C 5 column (250 9 10 mm; Phenomenex, Torrance, CA, USA) and linear gradient of acetonitrile concentration (0-60% in 60 min) in the presence of 0.1% trifluoroacetic acid, while on the second step > 98% purity was achieved by using a Vydac 218TP54 C 18 column (250 9 4.6 mm; Separations Group) and shallow acetonitrile gradient (25-50% in 50 min) in the presence of 0.1% trifluoroacetic acid. Molecular masses of the purified recombinant polypeptides were measured by MALDI-TOF MS. An Ultraflex TOF-TOF spectrometer (Bruker Daltonik, Bremen, Germany) in the linear positive-ion mode was used as described previously with the accuracy error not exceeding 100 p.p.m. [28] . Mass spectra were analyzed with the DATA ANALYSIS 4.3 and DATA ANALYSIS Viewer 4.3 software (Bruker).
Heterologous expression of Na v s
For expression in Xenopus laevis oocytes, linearized plasmids encoding rat (r) Na v 1.2, rNa v 1.4, human (h) Na v 1.5, murine (m) Na v 1.6, the insect channel BgNa v 1 and the auxiliary subunits rb1, hb1, and TipE, were transcribed using the T7 mMESSAGE-mMACHINE transcription kit (Ambion, Austin, TX, USA). Stages V and VI oocytes harvested from anesthetized female X. laevis frogs were injected with 
Electrophysiological characterization
Two-electrode voltage-clamp recordings were performed at room temperature using a GeneClamp 500 amplifier (Molecular Devices, Sunnyvale, CA, USA) controlled by a pClamp data acquisition system (Molecular Devices). Whole-cell currents from oocytes were recorded 1-5 days after injection. Voltage and current electrodes were filled with 3 M KCl. The resistances of both electrodes were kept between 0.7 and 1.7 MΩ. The elicited currents were sampled at 20 kHz and filtered at 2 kHz using a four-pole, low-pass Bessel filter. To eliminate the effect of the voltage drop across the bath-grounding electrode, a two-electrode bath clamp actively controlled the bath potential. Leak subtraction was performed using a ÀP/4 protocol. For the electrophysiological characterization, the following voltage protocol was applied from a holding potential of À90 mV with a start-to-start pulse frequency of 0.2 Hz. Current traces were evoked in oocytes expressing the cloned Na v channels by 100-ms depolarizations to the voltage corresponding to the maximal activation of the Na v channel subtype in control conditions. All data were tested for normality using a D'Agustino Pearson omnibus normality test. Data following a Gaussian distribution were analyzed for significance using one-way ANOVA and the Bonferroni test. Nonparametric data were analyzed for significance using the Kruskal-Wallis and Dunn's test.
Results and Discussion
Scorpion a-toxins with defined selectivity profile So far, several dozen scorpion a-toxins have been described. Some of them are well characterized, while others have been assigned to a-toxins by amino acid sequence similarities. Moreover, the characterized toxins are often assigned to a particular subgroup (mammal, insect, or a-like) based on different types of data: immunochemical, electrophysiological, or toxicological. Since no uniform set of data are available, we followed the common practice and used the following criteria to assign scorpion a-toxins to subgroups: (a) only toxins with available electrophysiological and/or toxicity data were analyzed; (b) if based on electrophysiological and/or toxicity data clear selectivity to mammals or insects was observed, we assigned this toxin to mammal or insect toxins correspondingly; (c) toxins were assigned to the a-like subgroup otherwise (Table S1 , Table 1 ). Note that mammal toxins are active on the Na v 1.2 isoform mostly at nanomolar concentrations. The existing classification of scorpion a-toxins is far from being perfect. Besides toxins being assigned to subgroups based on data from different types of experiments, some toxins are difficult to assign to any of the groups. Some toxins such as AaH IT4 target both a-and b-toxin binding sites [29] ; others such as Ts2 exhibit the a-effect but compete with b-toxins [30] , and some exert both a-and b-effects, e.g., BmK AGP-SYPU1 [31] . These examples do not satisfy the requirements of any of the existing (sub)groups.
Factors influencing the selectivity of scorpion a-toxins
Numerous mutagenesis and computational studies revealed important features of scorpion a-toxins that determine their selectivity. First, scanning or site-specific mutagenesis was performed for BmK M1 [9, 15, 16, 18, 19] , Lqh2 [17, 21, 22] , Lqh3 [20] , LqhaIT [12, 13, 17, 21, 22] , MeuNaTxa-5 [25] , OD1 [23, 24] , and BotXIV [14] and specific amino acid residues were found important for a-toxin specificity toward different phyla as a result. Second, analysis of toxin sequences allowed to put forward a hypothesis regarding the differential role of the core and specificity modules [17, 21] , which was further substantiated by experiments on transfer of respective toxin regions to the scaffold of their counterparts from another selectivity subgroup. This was reported for Aah2, BotXIV, Lqh2, and LqhaIT [14, 17, 21] . Third, it was demonstrated that the specificity modules of toxins from different selectivity subgroups are characterized by different physicochemical properties [8] . Mammal toxins possess a more hydrophilic and flexible specificity module, and the flexibility is presumably due to a pair of glycine residues (G4 and G17; Table 1 ). Fourth, several works have shown that molecular topology of the toxin also influences its selectivity: the specificity module of mammal toxins is flat in comparison with insect toxins [8, 11] .
Rationale for creation of a mammal-selective BeM9 derivative
Here, we demonstrate that the already available data on the selectivity of scorpion a-toxins are enough to modify rationally the activity profile of a chosen toxin. Unlike previous attempts [14, 17, 21] exploiting the scaffolds of mammal and insect toxins, we used the a-like toxin BeM9 from M. eupeus, the first scorpion a-toxin for which the NMR structure was determined [32] , and turned it into a mammal-selective toxin. Several changes were introduced into BeM9 structure to achieve the selectivity (Table 1) . First, we adapted the hydrophilicity of BeM9 specificity module by transferring the specificity module from a characteristic mammal toxin Aah2 [33] . Second, to ensure higher mobility of the specificity module we introduced glycines into positions 4 and 17 of BeM9. Both properties, i.e., elevated hydrophilicity and mobility of the specificity module, are characteristic of mammal toxins [8] . Third, we transferred residues located in the remaining positive selection sites and conserved positions of Aah2. These changes were introduced to BeM9 since (a) residues found under selection pressure in taxon-specific toxins probably interact with the target channels; and (b) conserved residues of toxins are thought to interact Table 1 . Alignment of scorpion a-toxins belonging to well established pharmacological subgroups. Residue numbering is according to BeM9. Residues involved in the specificity module are shaded by gray boxes. "Mammal", "Insect", "a-Like", and "All a-toxins" lines show the alignment consensuses; "PSS" designates the positive selection sites for all toxins in the table according to the references given. The " $ " sign marks toxins with C-terminal amidation. Residues with different properties are colored: cysteine, glycine, and proline residues are black; negatively charged, red; positively charged, blue; polar uncharged, green; aromatic, orange; and hydrophobic aliphatic, olive. "*" -conserved residues, ":" -conservative mutations, "." -semiconservative mutations, "˄" designates positive selection sites predicted in various studies. In msBeM9, positions differing from the parent polypeptide BeM9 are in bold and underlined.
with the conserved residues of the channels. Fourth, to achieve a flat relief in BeM9, which is presumed to be important for mammal selectivity [17] , we considered shortening the loop between the second and third cysteines (the so-called 'J-loop') by two residues; such manipulation was effective in changing the specificity of MeuNaTxa-5 [25] . Since these residues are at positive selection sites, this operation may be effectively considered as a simple transfer of the J-loop from Aah2. Finally, we introduced the E15F substitution involving the residue that has been shown to directly interact with F1610 in Na v 1.2 [21] , because just high anti-Na v 1.2 activity is a hallmark of mammal toxins (Table S1 ). The designed derivative of BeM9 was named msBeM9 (mammal-selective BeM9).
msBeM9 is a mammal a-toxin
BeM9 and its derivative were produced recombinantly in E. coli. Thioredoxin was used as a fusion partner, and no additional step for disulfide formation was required. CNBr cleavage and two-step reverse-phase HPLC were used to purify the polypeptides; the final yields of end-products were~2 mg per 1 L of bacterial culture. The measured and calculated molecular masses of BeM9 (measured: 7335.1 Da; calculated: 7335.3 Da) and msBeM9 (measured: 7103.5 Da; calculated: 7103.8 Da) matched closely, indicating disulfide bond formation. To determine the phyla and ion channel subtype selectivity, both BeM9 and its derivative msBeM9 were investigated for their activity on mammalian and insect Na v channels expressed in X. laevis oocytes. In accordance to what was previously reported, BeM9 at a concentration of 1 lM was found to affect both insect and mammalian Na v channels, with the exception of Na v 1.2 [8] (Fig. 2A) . At the same concentration, msBeM9 displayed a remarkably different pharmacological profile (Fig. 2B) : the toxin was no longer able to modulate the insect channel BgNa v 1 or the cardiac channel Na v 1.5. Even at concentrations of up to 5 lM, no activity was observed on these channels. Furthermore, msBeM9 did slow down the inactivation of Na v 1.2 channels. Also, it remained active on Na v 1.4 and Na v 1.6; however, the efficacy against Na v 1.4 channels was significantly reduced compared to BeM9. msBeM9 shows a typical mammal a-toxin selectivity profile.
Conclusions
In this study, we have changed the selectivity profile of the a-like toxin BeM9 toward mammal a-toxins on the basis of all available information on what determines scorpion a-toxin selectivity. We conclude that the scientific community has gathered enough information for the rational design of scorpion a-toxins selectively active on mammals or insects. 
